LAVA Return On Equity from 2010 to 2025

LVTX Stock  USD 1.16  0.11  8.66%   
LAVA Therapeutics Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity will likely drop to -0.95 in 2025. Return On Equity is a measure of the profitability of LAVA Therapeutics NV in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.91)
Current Value
(0.95)
Quarterly Volatility
0.42280619
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LAVA Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LAVA Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 661.5 K, Net Interest Income of 3.4 M or Depreciation And Amortization of 601.1 K, as well as many indicators such as Price To Sales Ratio of 2.02, Dividend Yield of 0.0 or PTB Ratio of 0.87. LAVA financial statements analysis is a perfect complement when working with LAVA Therapeutics Valuation or Volatility modules.
  
Check out the analysis of LAVA Therapeutics Correlation against competitors.

Latest LAVA Therapeutics' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of LAVA Therapeutics NV over the last few years. Return on Equity is the amount of LAVA Therapeutics net income returned as a percentage of LAVA Therapeutics equity. Return on equity measures LAVA Therapeutics profitability by revealing how much profit LAVA Therapeutics NV generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. LAVA Therapeutics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LAVA Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.6310 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

LAVA Return On Equity Regression Statistics

Arithmetic Mean(1.23)
Geometric Mean1.12
Coefficient Of Variation(34.39)
Mean Deviation0.35
Median(1.46)
Standard Deviation0.42
Sample Variance0.18
Range1.3855
R-Value0.64
Mean Square Error0.11
R-Squared0.41
Significance0.01
Slope0.06
Total Sum of Squares2.68

LAVA Return On Equity History

2025 -0.95
2024 -0.91
2023 -0.82
2022 -0.37
2021 -0.32
2020 -1.7

About LAVA Therapeutics Financial Statements

LAVA Therapeutics investors use historical fundamental indicators, such as LAVA Therapeutics' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LAVA Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(0.91)(0.95)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LAVA Stock Analysis

When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.